Insider Selling: Israel Ben-Yoram Sells 44,797 Shares of Pluristem Therapeutics Stock (PSTI)
Pluristem Therapeutics (NASDAQ:PSTI) Director Israel Ben-Yoram sold 44,797 shares of Pluristem Therapeutics stock in a transaction that occurred on Wednesday, January 8th. The shares were sold at an average price of $4.12, for a total transaction of $184,563.64. Following the transaction, the director now directly owns 376,884 shares in the company, valued at approximately $1,552,762. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Pluristem Therapeutics (NASDAQ:PSTI) remained flat at $4.21 during trading on Thursday. The stock had a trading volume of 647,590 shares. Pluristem Therapeutics has a 52 week low of $2.47 and a 52 week high of $4.28. The stock has a 50-day moving average of $3.37 and a 200-day moving average of $3.25. The company’s market cap is $252.1 million.
Pluristem Therapeutics Inc (NASDAQ:PSTI) is a bio-therapeutics company engaged in the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.